NDC product
Phentermine and topiramate
NDC 0480-3295 · Teva Pharmaceuticals, Inc.
Key facts
| Product NDC | 0480-3295 |
|---|---|
| Proprietary name | Phentermine and topiramate |
| Nonproprietary name | Phentermine and topiramate |
| Substances | PHENTERMINE HYDROCHLORIDE, TOPIRAMATE |
| Dosage form | CAPSULE, EXTENDED RELEASE |
| Route | ORAL |
| Labeler | Teva Pharmaceuticals, Inc. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA204982 |
| DEA schedule | CIV |
| Pharmacologic classes | Appetite Suppression [PE], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC] |
| Marketing start | May 7, 2025 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: